Incidence of new Primary Malignancies Among Patients With Bone Metastases From Breast, Prostate, or Lung Cancer Treated With XGEVA or Intravenous Zoledronic Acid: a Retrospective Cohort Study (20170728)

26/09/2018
28/02/2020
EU PAS number:
EUPAS25381
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20170728_01.02.06 Public Redacted Protocol Ver 1.0 English

English (703.48 KB - PDF) View document
Study results
Study results

01.09.01 Clinical Study Report ORSR Abstract 2020-01-29 20170728 Final Analysis

English (85.58 KB - PDF) View document
Study report
Other information